News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website


Voyager Pediatric System Granted Humanitarian Use Designation


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

This is interesting..  the FDA apparently approved a device without requiring any proof that it helps at all.  My first instinct was to dismiss it as nonsense, but the press release says that Dr. Michael Prados is on the scientific advisory board - he is one of the best neuro-oncologists in the world, so we cannot dismiss this.  I made the same mistake with Optune - I completely dismissed it at first glance, until I saw the research results and met patients who did well with it. This works in a completely different way than Optune. 


Posted on: 02/23/2018

Voyager Pediatric System Granted Humanitarian Use Designation

 




Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740